- Research article
- Open Access
Regions of Diversity 8, 9 and 13 contribute to Streptococcus pneumoniae virulence
© Embry et al; licensee BioMed Central Ltd. 2007
Received: 12 February 2007
Accepted: 27 August 2007
Published: 27 August 2007
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia. Previously, using comparative genomic analyses, 13 regions of genomic plasticity have been identified in the S. pneumoniae genome. These "Regions of Diversity" (RDs) accounted for half the genomic variation observed amongst all pneumococci tested, moreover, were determined to encode a variety of putative virulence factors. To date, genes within 5 RDs have been unequivocally demonstrated to contribute to S. pneumoniae virulence. It is unknown if the remaining RDs also contribute to virulence.
Using allelic exchange, we created S. pneumoniae mutants that were deficient in RD2, 5, 7, 8, 9, 12 and 13. Mutants deficient in RD8, 9 and 13 were attenuated in a mouse model of disease. RD8 is 40,358 nucleotides in length and encodes 37 genes. Using a panel of isogenic mutants, we determined that RD8b3 is the operon within RD8 that is responsible for virulence. Mice infected with mutants deficient in RD8, RD8b3, RD9 and RD13 had significantly less bacteria in the blood two days after intranasal challenge and improved survival over time versus mice infected with wild type. In all instances mutants colonized the nasopharynx at levels equivalent to wild type.
Genes within RD1, 3, 4, 6, and 10 have previously been shown to contribute to virulence. This study demonstrates that genes within RD8, 9 and 13 also contribute to virulence. The ability of mutants deficient in RD2, 5, 7, 8, 9, 12, and 13 to colonize the nasopharynx indicates that genes within these RDs are not required for asymptomatic carriage. Nonetheless, the observation that mutants deficient in RD8b3, 9 and 13 are attenuated indicates that genes within these loci are necessary for spread of the bacteria beyond the nasopharynx to normally sterile sites.
Streptococcus pneumoniae (the pneumococcus) is a leading cause of community-acquired pneumonia, sepsis, and meningitis. Primarily a commensal, invasive pneumococcal disease (IPD) is characterized by spread of the pneumococcus from the nasopharynx to normally sterile sites such as the lungs, blood, and central nervous system. At risk for IPD are young children, the elderly, and individuals who are immunocompromised or have underlying medical conditions such as sickle cell anemia. Worldwide, it is estimated that S. pneumoniae is responsible for 15 cases of IPD per 100,000 persons per year and over a million deaths annually [1, 2]. Of note, the preponderance of invasive disease is the result of infection with a relatively few invasive clones , a finding that suggests invasive clones carry genes that facilitate disease progression that are absent in non-invasive isolates.
In 2001, the primary nucleotide sequence of three S. pneumoniae genomes became publicly available [4–6]. In 2004, comparative genomic hybridization analysis of 10 clinical isolates using microarrays determined that 13 large loci, hence forth termed Regions of Diversity (RD1-13), accounted for half the genomic variation observed among all pneumococci (approximately 10% of the genome of each isolate) . Genomic comparisons, performed by either microarrays or direct sequencing suggested that these 13 RDs are regions of genome plasticity and are unequally distributed among clones and serotype [7, 8]. These findings were confirmed by Bruckner et al., who using DNA from 20 S. pneumoniae isolates and microarrays, identified 13 clusters of 4 kb and larger that were not shared by a variety of genetically different S. pneumoniae strains . Of the 13 RDs, 7 have been associated with atypical GC content and 8 have been determined to be flanked by remnants of mobile genetic elements ; findings that indicate these RDs were most likely acquired by horizontal transfer.
Regions of Diversity in S. pneumoniae and their function
Regions of Diversity†
% GC content
Genes included in RD: TIGR annotation
Encoded virulence determinants
ZmpC; zinc metalloproteinase C
capsular polysacharide synthesis operon
RlrA pathogenicity islet
PPI1, pneumococcal pathogenicity island I
PsrP-secY2A2 pathogenicity island
Challenge of mice with S. pneumoniae mutants deficient in RD
S. pneumoniae titers in nasopharyngeal lavage elute collected from mice
Challenge of mice with S. pneumoniae mutants deficient in RD8 operons
To determine the operon(s) within RD8b that were responsible for virulence, we created isogenic mutants deficient in the operons RD8b1, RD8b2 and RD8b3 and challenged mice with these mutants. Deletion of RD8b1 or RD8b2 failed to have a statistically significant impact on virulence. Mice infected with T4 ΩRD8b1 and T4 ΩRD8b2 had bacterial titers in the blood equivalent to wild type at day 2 and a survival rate comparable to wild type infected mice (Figure 4 and 5). In contrast, deletion of RD8b3 attenuated TIGR4 virulence. Mice infected with T4 ΩRD8b3 had 40-fold less bacteria in the blood than mice infected with TIGR4 (Figure 4), and demonstrated improved survival over time (Figure 5). Thus genes within RD8b3 were in large part responsible for the virulence associated with RD8.
Unlike deletion of RD8b1-3 (T4 ΩRD8b), it is of note that deletion of RD8b3 did not completely attenuate TIGR4 virulence. Moreover, the mutant T4 ΩRD8b1 was not fully virulent. At day 2 mice infected with T4 ΩRD8b1 had a median bacterial titer in the blood 10-fold lower than wild type (p = 0.337), likewise, mice infected with T4 ΩRD8b1 demonstrated a delay in time of death (p = 0.09), albeit these differences were not significant. Thus it seems that genes within RD8b1 might also contribute to virulence, but not in a manner sufficient to demonstrate statistical significance in this challenge model.
TIGR4 growth in media with ribulose and fucose as the sole carbon source
Based on nucleotide sequence homology, genes within RD9 and RD13 encode proteins that transport ribulose and fucose, respectively (see Discussion). To test this prediction, we determined if deletion of RD9 and RD13 affected the ability of TIGR4 to grow in media containing either ribulose or fucose as the sole carbon source. In all instances TIGR4, T4 ΩRD9 and T4 ΩRD13 grew normally in regular C+Y (0.15% glucose and 0.2% sucrose; data not shown). However, neither TIGR4 nor the mutants were able to grow in media containing ribulose (0.1–0.5%) or fucose (0.1–0.5%) as the sole carbon source (data not shown). Thus ribulose or fucose is not sufficient to support TIGR4 growth despite the presence of RD9 and RD13.
It is well established that the propensity of a S. pneumoniae isolate to cause invasive disease is dependent on the interplay between serotype and genotype. Molecular epidemiology has demonstrated that invasive and non-invasive clones exist within invasive serotypes . Kelly et al. have shown that conversion of a virulent serotype 5 isolate to serotype 3 ablated virulence in mice, whereas conversion of a 6B isolate to serotype 3 lowered the LD50 by >100-fold . It is also known that the genomic component of virulence (i.e. that excluding genes that encode capsular polysaccharide) is dependent on the presence of horizontally acquired genes that complement the core genome. Previously, we have demonstrated that RDs known to contribute to virulence are unequally distributed among invasive and non-invasive isolates in a serotype-dependent manner . Likewise, the absence of non-core, non-RD associated virulence genes, such as those encoding the adhesin Choline Binding Protein A (CbpA), have been demonstrated to diminish the ability of an isolate to progress from the nasopharynx to the lungs and bloodstream .
To date, RD1, 3, 4, 6 and 10 have been conclusively shown to contribute to virulence by deletion and disruption mutagenesis [8, 10–16, 18, 19, 23]. The purpose of this study was to determine if the 8 uncharacterized RDs (RD2, 5, 7, 8, 9, 11, 12 and 13) also contribute to virulence. Because all 13 RDs are present in TIGR4 , we chose to use it as the parent strain for these analyses.
The fact that we were able to create deletion mutants deficient in RD2, 5, 7, 8, 9, 12 and 13, moreover, that these mutants colonized the nasopharynx of mice normally, indicates that genes within these RDs were not essential in vitro nor required in vivo by TIGR4 for asymptomatic carriage. Given that the human nasopharynx is the sole ecological niche of S. pneumoniae, this finding is consistent with the fact that RDs are not present in all clinical isolates and serve as accessory genes. Notably, we were unable to create a mutant deficient in RD11 despite several attempts. RD11 encodes a protein homologous to the high affinity phosphate transport system (PstSABC) regulatory protein, PhoU. Studies have shown that PstSABC is expressed in response to low levels of phosphate and that deletion of PhoU in strain R6X has pleiotropic effects including delayed growth and an inability to undergo autolysis [24, 25]. Thus, one possible explanation for our inability to create an RD11 mutant is that its deletion negatively impacts the ability of TIGR4 to acquire phosphate.
Challenge of mice with the panel of RD mutants demonstrated that genes within RD8b3, 9 and 13 were required by TIGR4 to cause invasive disease. Given that mutants deficient in these RD colonized the nasopharynx normally, it can be inferred that these loci encode virulence determinants that are not required for colonization but instead facilitate spread of the bacteria to normally sterile sites. How these loci contribute to virulence remains to be determined.
RD8 is composed of two pathogenicity islands located adjacent to each other on the TIGR4 chromosome. Previously, using comparative genomic analysis, we determined that the presence of RD8a was positively correlated with the ability of serotype 6A and 6B clinical isolates to cause invasive human disease. Likewise, we determined that genes within RD8b were correlated with the non-invasive phenotype . In this manuscript we demonstrate that deletion of RD8a has no impact on TIGR4 virulence, whereas deletion of RD8b ablates TIGR4 virulence. Thus a discrepancy exists between the findings of this study and those from our previous comparative genomic analysis. One explanation for this discrepancy may be the differences in strains. Comparative genomic analyses was performed using 72 clinical isolates of serotype 6A, 6B and 14, whereas this study was limited to a single serotype 4 isolate. Thus it is possible that genotype (i.e. gene redundancy, transcriptional regulation, etc...) and serotype dependent factors (i.e. resistance to opsonophagocytosis, ability to adhere to cells) have a large impact on the requirement of RDs for virulence. This would be in accordance with the findings reported by Kelly et al. that are described above, moreover, explain why RDs known to be required for virulence in one strain are not found in others. For example zmpC, a zinc metalloproteinase encoded within RD1, is present in only 25% of clinical isolates . This finding also suggests that it is not possible to evaluate the role of any single gene or operon in any single strain or serotype.
Possible roles of RD8b3, RD9 and RD13
The operon RD8b3 is composed of 7 genes: 6 small hypothetical genes (SP1345, SP1347-49, SP1351), a conserved domain protein (SP1350), and a putative membrane protein (SP1346). BLASTP analysis of the predicted amino acid sequence of these genes finds homologues in other streptococci and gram-positive bacteria, but no indication of function with exception to SP1346. SP1346 is identified as a member of the CAAX amino terminal protease family. Members of this family include the bacteriocin-like immunity protein PlnP from Lactobacillus plantarum . PlnP mediates protection against highly charged cationic proteins that are expressed from the same operon. Interestingly, SP1345, SP1347, SP1350 are less than 150 amino acids in length and have a pI greater than 9. SP1349 and SP1351 are less than 100 amino acids in length have a pI less than 4. Thus, SP1346 may be an immunity-like protein that protects the bacteria from cationic and anionic peptides (presumably the hypothetical proteins), that may serve to impair the host defence. Future studies are warranted to determine if this is the case.
RD9 encodes a single operon composed of 11 genes. It encodes a transketolase, a ribulose phosphate 3-epimerase, a sugar phosphotransferase (PTS) system, and a transcriptional terminator. RD13 is also a single operon composed of 9 genes. It encodes an L-fucose isomerase, a fucolin-related protein, an L-fucose aldolase, a PTS transport system, and a conserved hypothetical protein. Thus RD9 and RD13 encode genes that may contribute to ribulose and fucose uptake.
In context with what is known in regards to RD6 (iron uptake) [18, 19, 23] and RD11 (phosphate uptake) , the finding that mutants deficient in RD9 and RD13 are attenuated suggests that acquisition of ribulose and fucose are essential for TIGR4 during the disease process. Unfortunately, TIGR4 failed to grow in media that contained ribulose or fucose as the sole carbon source. This finding brings up the possibility that: 1) ribulose and fucose play a role in secondary metabolism, which indirectly contributes to virulence, but alone are not sufficient to support bacterial growth. 2) That these RDs do not transport sugars and contribute to virulence in an undefined manner. As with RD8b3, future experiments are warranted to determine the mechanism by which these loci contribute to virulence.
The goal of this study was to determine the virulence contribution of the 8 uncharacterized S. pneumoniae RDs. Having done so, we can now focus future efforts on characterization of genes within RD8b3, RD9 and RD13. Future studies will focus on the role RD8b3 as a potential bacteriocin-like system that mediates virulence, and the requirement for fucose and ribulose in vivo. Of the 13 S. pneumoniae RDs identified by Tettelin et al., and Bruckner, seven have now been conclusively demonstrated to play a role in virulence. This strongly suggests that the propensity of an isolate to cause invasive disease is dependent on the presence of horizontally acquired genes that complement the core virulence genes present.
Bacterial strains and components
S. pneumoniae serotype 4, strain TIGR4  and its isogenic mutants were grown in defined semi-synthetic casein liquid media supplemented with 0.5% yeast extract (C+Y)  and tryptic soy blood agar plates (Remel, Lenexa, KS) at 37°C in 5% CO2. Mutants with deleted RDs were grown with erythromycin at 1 μg/ml (Sigma-Aldrich, St. Louis, MO). Escherichia coli TOP10 cells (Invitrogen, Carlsbad, CA) containing the vector pCR2.1 (Invitrogen) and subsequent recombinant plasmids were selected on Luria Bertani agar plates containing 1 mg/ml erythromycin. Standard molecular techniques were used for plasmid DNA manipulation and transformation of E. coli .
Creation of Region of Diversity (ΩRD) mutants
PCR primers used to create T4ΩRD mutants and the corresponding genes deleted
Genes deleted: TIGR annotation
Primers used to amplify flanking DNA fragments for PCR construct deletion mutagenesis†
SP0162 F: NNNNNaagcttGGGATTGGGCTCCTATG
SP0168 F: NNNNNgcggccgcGTACCAACAAATACCTC
SP0163 R: NNNNNactagtCTGCTAAAGATAGG
SP0170 R: NNNNNtctagaTCTAACTCTTCATAG
SP0694 F: NNNNNaagcttCCTATCTTGTTGTCATTA
SP0698 F: NNNNNgcggccgcATGGGAACTACTCC
SP0694 R: NNNNNactagtCGTAGAACATATTTCGTCC
SP1130 F: NNNNNaagcttCAATTTCTGAAGGTCCG
SP1145 F: NNNNNgcggccgcCATACTGATGATGAGG
SP1130 R: NNNNNactagtGTTTAAGCCATGGCG
SP1146 R: NNNNNtctagaCCATAACTAACTCTCC
SP1315 F: NNNNNgcggccgcACTTCGGAAAGAAGTGG
SP1352 F: NNNNNaagcttGTTTCAATGCCCAGCTTCGTCC
SP1315 R: NNNNNtctagaCTTCACTTTCATAATACG
SP1352 R: NNNNNactagtCTTTAATGCATCATTAACGACGC
SP1331 F: NNNNNaagcttTGTTACTGCAAAAAGAAC
SP1331 R: NNNNNactagtGCGCCTTTATCTGCAGC
SP1332 F: NNNNNgcggccgcGAATTTCTTTGTATCGG
SP1332 R: NNNNNtctagaGCAGCAAACTATAAAC
SP1337 F: NNNNNaagcttCAGTTTACCAAATCATC
SP1337 R: NNNNNactagtCTGCCTCTTCAGAACAATAACG
SP1339 F: NNNNNgcggccgcTGCGGTAACTGGAGTG
SP1344 F: NNNNNaagcttTAAAATATACTGGCACGG
SP1338 R: NNNNNtctagaTTCTTCTCTACAAGCTC
SP1344 R: CGATGTAGTTactagtGCC
SP1346 F: NNNNNgcggccgcCCAACAAGTAAATGTCC
SP1615 F: NNNNNaagcttGGGACTTAACTTGAGC
SP1621 F: NNNNNgcggccgcATAGGGAATGTTTACCC
SP1615 R: NNNNNactagtCCATTCAGGAGTTGCC
SP1621 R: NNNNNtctagaAAACAAGAAC
SP1950 F: NNNNNaagcttACGAGTGGATTGAC
SP1957 F: NNNNNgcggccgcGATTGAACTTAAACAGG
SP1950 R: NNNNNactagtCTTCATAGCTGTGATCCG
SP1957 R: NNNNNtctagaGCCATCTCCCAAATTGCC
SP2158 F: NNNNNaagcttGGAATTCTCAACATAG
SP2166 F: NNNNNgcggccgcCATCTCCTCATCAGG
SP2158 R: NNNNNactagtCCACAAATCTTTGC
SP2166 R: NNNNNtctagaCAGATTTGACGAAAGG
Intranasal challenge model
Five week old female BALB/cJ mice (Jackson Laboratory, Bar Harbor, ME) were maintained in biosafety level 2 facilities at The University of Texas Health Science Center in San Antonio. All experiments were performed with mice under general anaesthesia with inhaled isoflurane (2.5%; Baxter Healthcare Corp., Deerfield, IL). S. pneumonia, 104 cfu (low dose colonization model) or 107 cfu (invasive disease model) in 20 μl phosphate buffered saline (PBS) was administered drop-wise to the external nares of mice. On day 2, 4, 7 and 10 bacterial titers in the blood were determined by collection of blood from the tail vein, serial dilution and plating. Bacterial titers in the nasopharynx were determined on days 2, 7, and 14 by serial dilution and plating of nasopharyngeal lavage obtained by instillation of 20 μl PBS into the right nostril and collection of elute from the left. Statistical analysis of bacterial titers was performed using a nonparametric independent group analysis (Mann-Whitney rank sum).
Ribulose and fucose growth curves
Exponential phase cultures (OD620 = 0.5) of TIGR4, T4 ΩRD9 and T4 ΩRD13 were grown in C+Y, centrifuged, washed, and suspended in PBS. Borosilicate glass tubes (15 × 100 mm) containing 5 ml of normal C+Y (0.15% glucose, 0.2% sucrose), C+Y with ribulose as the sole carbon source (0.1–0.5% fucose), and C+Y with fucose as the sole carbon source (0.1–0.5% fucose) were inoculated with 100 μl of bacterial suspensions (final concentration: 105 cfu/ml) and grown at 37°C in 5% CO2. Microbial growth was measured by determining the optical density of the culture at OD620 on an hourly basis for 6 hours. Three cultures were measured at each time point for each of the bacteria tested.
Statistical analysis of mouse survival over time was performed using a Gehan-Breslow statistic analysis for survival. Statistical analysis of bacterial titers in the blood and nasal lavage was performed using a Mann-Whitney Rank Sum Test.
This work is supported by project grant 121919 of the Executive Research Committee Research fund at UTHSCSA.
- Pneumococcal vaccines. WHO position paper. Wkly Epidemiol Rec. 1999, 74 (23): 177-183.Google Scholar
- Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000, 49 (RR-9): 1-35.Google Scholar
- Sandgren A, Sjostrom K, Olsson-Liljequist B, Christensson B, Samuelsson A, Kronvall G, Henriques Normark B: Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis. 2004, 189 (5): 785-796. 10.1086/381686.View ArticlePubMedGoogle Scholar
- Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ, Durkin AS, Gwinn M, Kolonay JF, Nelson WC, Peterson JD, Umayam LA, White O, Salzberg SL, Lewis MR, Radune D, Holtzapple E, Khouri H, Wolf AM, Utterback TR, Hansen CL, McDonald LA, Feldblyum TV, Angiuoli S, Dickinson T, Hickey EK, Holt IE, Loftus BJ, Yang F, Smith HO, Venter JC, Dougherty BA, Morrison DA, Hollingshead SK, Fraser CM: Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science. 2001, 293 (5529): 498-506. 10.1126/science.1061217.View ArticlePubMedGoogle Scholar
- Hoskins J, Alborn WE, Arnold J, Blaszczak LC, Burgett S, DeHoff BS, Estrem ST, Fritz L, Fu DJ, Fuller W, Geringer C, Gilmour R, Glass JS, Khoja H, Kraft AR, Lagace RE, LeBlanc DJ, Lee LN, Lefkowitz EJ, Lu J, Matsushima P, McAhren SM, McHenney M, McLeaster K, Mundy CW, Nicas TI, Norris FH, O'Gara M, Peery RB, Robertson GT, Rockey P, Sun PM, Winkler ME, Yang Y, Young-Bellido M, Zhao G, Zook CA, Baltz RH, Jaskunas SR, Rosteck PR, Skatrud PL, Glass JI: Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol. 2001, 183 (19): 5709-5717. 10.1128/JB.183.19.5709-5717.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Dopazo J, Mendoza A, Herrero J, Caldara F, Humbert Y, Friedli L, Guerrier M, Grand-Schenk E, Gandin C, de Francesco M, Polissi A, Buell G, Feger G, Garcia E, Peitsch M, Garcia-Bustos JF: Annotated draft genomic sequence from a Streptococcus pneumoniae type 19F clinical isolate. Microb Drug Resist. 2001, 7 (2): 99-125. 10.1089/10766290152044995.View ArticlePubMedGoogle Scholar
- Tettelin H, Hollingshead SK: Comparative genomics of Streptococcus pneumoniae: Intrastrain diversity and genome plasticity. The Pneumcoccus. Edited by: Tuomanen EI, Mitchell T, Morrison DA, Spratt BG. 2004, Washington D.C. , ASM press, 15-29.Google Scholar
- Obert C, Sublett J, Kaushal D, Hinojosa E, Barton T, Tuomanen EI, Orihuela CJ: Identification of a Candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease. Infect Immun. 2006, 74 (8): 4766-4777. 10.1128/IAI.00316-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Bruckner R, Nuhn M, Reichmann P, Weber B, Hakenbeck R: Mosaic genes and mosaic chromosomes-genomic variation in Streptococcus pneumoniae. Int J Med Microbiol. 2004, 294 (2-3): 157-168. 10.1016/j.ijmm.2004.06.019.View ArticlePubMedGoogle Scholar
- Camilli R, Pettini E, Grosso MD, Pozzi G, Pantosti A, Oggioni MR: Zinc metalloproteinase genes in clinical isolates of Streptococcus pneumoniae: association of the full array with a clonal cluster comprising serotypes 8 and 11A. Microbiology. 2006, 152 (Pt 2): 313-321. 10.1099/mic.0.28417-0.View ArticlePubMedGoogle Scholar
- Oggioni MR, Memmi G, Maggi T, Chiavolini D, Iannelli F, Pozzi G: Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Mol Microbiol. 2003, 49 (3): 795-805. 10.1046/j.1365-2958.2003.03596.x.View ArticlePubMedGoogle Scholar
- Watson DA, Musher DM: Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. Infect Immun. 1990, 58 (9): 3135-3138.PubMed CentralPubMedGoogle Scholar
- Hava DL, Camilli A: Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol. 2002, 45 (5): 1389-1406.PubMed CentralPubMedGoogle Scholar
- Hava DL, Hemsley CJ, Camilli A: Transcriptional regulation in the Streptococcus pneumoniae rlrA pathogenicity islet by RlrA. J Bacteriol. 2003, 185 (2): 413-421. 10.1128/JB.185.2.413-421.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Barocchi MA, Ries J, Zogaj X, Hemsley C, Albiger B, Kanth A, Dahlberg S, Fernebro J, Moschioni M, Masignani V, Hultenby K, Taddei AR, Beiter K, Wartha F, von Euler A, Covacci A, Holden DW, Normark S, Rappuoli R, Henriques-Normark B: A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci U S A. 2006Google Scholar
- Brown JS, Gilliland SM, Holden DW: A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence. Mol Microbiol. 2001, 40 (3): 572-585. 10.1046/j.1365-2958.2001.02414.x.View ArticlePubMedGoogle Scholar
- Brown JS, Gilliland SM, Basavanna S, Holden DW: phgABC, a three-gene operon required for growth of Streptococcus pneumoniae in hyperosmotic medium and in vivo. Infect Immun. 2004, 72 (8): 4579-4588. 10.1128/IAI.72.8.4579-4588.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Brown JS, Gilliland SM, Ruiz-Albert J, Holden DW: Characterization of pit, a Streptococcus pneumoniae iron uptake ABC transporter. Infect Immun. 2002, 70 (8): 4389-4398. 10.1128/IAI.70.8.4389-4398.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Brown JS, Gilliland SM, Spratt BG, Holden DW: A locus contained within a variable region of pneumococcal pathogenicity island 1 contributes to virulence in mice. Infect Immun. 2004, 72 (3): 1587-1593. 10.1128/IAI.72.3.1587-1593.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Sandgren A, Albiger B, Orihuela CJ, Tuomanen E, Normark S, Henriques-Normark B: Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans. J Infect Dis. 2005, 192 (5): 791-800. 10.1086/432513.View ArticlePubMedGoogle Scholar
- Kelly T, Dillard JP, Yother J: Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae. Infect Immun. 1994, 62 (5): 1813-1819.PubMed CentralPubMedGoogle Scholar
- Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI: Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis. 2004, 190 (9): 1661-1669. 10.1086/424596.View ArticlePubMedGoogle Scholar
- Novak R, Cauwels A, Charpentier E, Tuomanen E: Identification of a Streptococcus pneumoniae gene locus encoding proteins of an ABC phosphate transporter and a two-component regulatory system. J Bacteriol. 1999, 181 (4): 1126-1133.PubMed CentralPubMedGoogle Scholar
- Orihuela CJ, Mills J, Robb CW, Wilson CJ, Watson DA, Niesel DW: Streptococcus pneumoniae PstS production is phosphate responsive and enhanced during growth in the murine peritoneal cavity. Infect Immun. 2001, 69 (12): 7565-7571. 10.1128/IAI.69.12.7565-7571.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Chiavolini D, Memmi G, Maggi T, Iannelli F, Pozzi G, Oggioni MR: The three extra-cellular zinc metalloproteinases of Streptococcus pneumoniae have a different impact on virulence in mice. BMC Microbiol. 2003, 3: 14-10.1186/1471-2180-3-14.PubMed CentralView ArticlePubMedGoogle Scholar
- Diep DB, Havarstein LS, Nes IF: Characterization of the locus responsible for the bacteriocin production in Lactobacillus plantarum C11. J Bacteriol. 1996, 178 (15): 4472-4483.PubMed CentralPubMedGoogle Scholar
- Brown JS, Holden DW: Iron acquisition by Gram-positive bacterial pathogens. Microbes Infect. 2002, 4 (11): 1149-1156. 10.1016/S1286-4579(02)01640-4.View ArticlePubMedGoogle Scholar
- Tomasz A: Choline in the cell wall of a bacterium: novel type of polymer-linked choline in pneumococcus. Science. 1967, 157: 694-697. 10.1126/science.157.3789.694.View ArticlePubMedGoogle Scholar
- Sambrook J, Fitsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 1989, Cold Spring Harbor , Cold Spring Harbor PressGoogle Scholar
- Horton RM: PCR-mediated recombination and mutagenesis. SOEing together tailor-made genes. Mol Biotechnol. 1995, 3 (2): 93-99.View ArticlePubMedGoogle Scholar
- Poyart C, Trieu-Cuot P: A broad-host-range mobilizable shuttle vector for the construction of transcriptional fusions to beta-galactosidase in gram-positive bacteria. FEMS Microbiol Lett. 1997, 156 (2): 193-198.View ArticlePubMedGoogle Scholar
- Bricker AL, Camilli A: Transformation of a type 4 encapsulated strain of Streptococcus pneumoniae. FEMS Microbiol Lett. 1999, 172 (2): 131-135. 10.1111/j.1574-6968.1999.tb13460.x.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.